-
Mashup Score: 3ARC TALKS Webinar: Kidney Disease Presentation in Amyloidosis - 8 month(s) ago
In this ARC Talks webinar, nephrologist Dr. Nelson Leung will focus on the implications of kidney involvement in amyloidosis patients …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2ARC TALKS Webinar: Kidney Disease Presentation in Amyloidosis - 8 month(s) ago
In this ARC Talks webinar, nephrologist Dr. Nelson Leung will focus on the implications of kidney involvement in amyloidosis patients …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📅 #ARCTALKS Webinar: Monday, August 21 Leading #nephrologist Dr. Nelson Leung will focus on the implications of kidney involvement in #amyloidosis patients with #AL, #ATTR, #AA, #ALECT2, and other forms: https://t.co/6qWfeWsRzL
-
-
Mashup Score: 1ARC 2022 Community Survey Results - 9 month(s) ago
Over 1200 responses were completed for the 2022 ARC Community Survey during April and May of that year. 79% of participants identified …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We'd like to take a moment and thank the organizations that supported our 2022 #amyloidosis Community Survey. Without them, this critical insight into the impact of #AL #ATTR #AA and other types wouldn't have been possible: https://t.co/lMV2pZxHyD
-
-
Mashup Score: 3ARC 2022 Community Survey Results - 9 month(s) ago
Over 1200 responses were completed for the 2022 ARC Community Survey during April and May of that year. 79% of participants identified …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Over 1200 #amyloidosis patients and caregivers participated in our 2022 Community Survey during April and May of last year. See what they had to share about their #AL #ATTR #AA and other amyloidosis journeys: https://t.co/lMV2pZxHyD
-
-
Mashup Score: 1
Contrastive learning based vision-language joint pre-training has emerged as a successful representation learning strategy. In this paper, we present a prototype representation learning framework…
Source: arXiv.orgCategories: Cardiologists, Latest HeadlinesTweet-
A new method for better learning from medical images and their written reports. Focuses on detailed image-report links and uses a unique method to reconstruct and exchange information between images and reports. #AL #MachineLearning #medtwitter https://t.co/bXoeWfVcaC
-
-
Mashup Score: 7
The billionaire aims to build a “maximally curious” AI that is not “politically correct,” Musk said on a Twitter Spaces session late Friday.
Source: CNBCCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @JohnNosta: Elon Musk plans Tesla and Twitter collaborations with xAI, his new startup. #AL #LLMs https://t.co/KS8S714zP8
-
Elon Musk plans Tesla and Twitter collaborations with xAI, his new startup. #AL #LLMs https://t.co/KS8S714zP8
-
-
Mashup Score: 0HealthTech Startup BrainSightAI Secures ~ ₹1 Crore from InfoEdge Subsidiary RedStart Labs - 10 month(s) ago
RedStart Labs, a subsidiary of InfoEdge formed in 2020, has invested close to Rs 1 crore in Bengaluru-based health technology startup BrainSightAI
Categories: Healthcare Professionals, Latest HeadlinesTweet-
#India #HealthTech #Startup @BrainSightAI Secures ~ ₹1 Crore; has 2 #Al solutions Voxelbox gives clinicians with access to #fMRI processing engine, #ML models to generate reports for CDS Snowdrop is a Patient care app for treatment schedule compliance https://t.co/hrSfsl7h2z
-
-
Mashup Score: 1
In this ARC TALKS webinar, Dr. Heather Landau discussed current treatment options for relapsed and refractory AL amyloidosis patients.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In Case You Missed It: Dr. Heather Landau discussed current treatment options for relapsed & refractory #AL #amyloidosis patients in our most recent #ARCTALKS webinar: https://t.co/6cXwYURS7h
-
-
Mashup Score: 3ARC Talks Webinar: Clinical Trials 101 and Advances in Research - 11 month(s) ago
In this ARC Talks Webinar, Dr. Morie Gertz gave a 101 overview of clinical trials, including consideration in how they are designed, and the phases needed fo…
Source: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In Case You Missed It: Dr. @MorieGertz gave a 101 overview of #ClinicalTrials for #amyloidosis and discussed current trials that are evaluating the next generation of drugs for the treatment of #AL and #ATTR in our recent #ARCTALKS webinar: https://t.co/ubHoYTksEE
-
-
Mashup Score: 1
The Amyloidosis Research Consortium is a nonprofit accelerating the development of and access to new and innovative treatments. We are driving the research that will have the greatest impact on length and quality of life for patients.
Source: Amyloidosis Research ConsortiumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A diagnosis of light chain amyloidosis (#AL #amyloidosis) can be confusing and stressful, bringing up many feelings and questions. Learn more about the disease and how it might affect you with our informational booklets: https://t.co/hBGLVdcE3w
-
Happening Now! Don't miss Dr. Nelson Leung speaking about the implications of kidney involvement in #amyloidosis patients with #AL, #ATTR, #AA, #ALECT2, and other forms: https://t.co/6qWfeWsRzL https://t.co/ZqtDfJMNqs